| Initial outcomes of integrated community-based hepatitis C treatment for people who inject drugs: findings from the Queensland Injectors’ Health Network L Morris, A Smirnov, A Kvassay, E Leslie, R Kavanagh, N Alexander, ... International Journal of Drug Policy 47, 216-220, 2017 | 96 | 2017 |
| Safety and efficacy of weight‐loss pharmacotherapy in persons living with HIV: a review of the literature and potential drug‐drug interactions with antiretroviral therapy RJ Cope, BS Fischetti, RK Kavanagh, TM Lepa, MA Sorbera Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 39 (12 …, 2019 | 16 | 2019 |
| Antiviral drugs E Cani, TE Park, R Kavanagh Side Effects of Drugs Annual 41, 301-319, 2019 | 7 | 2019 |
| Antihypertensive drugs R Kavanagh Side Effects of Drugs Annual 42, 215-226, 2020 | 2 | 2020 |
| Antihypertensive drugs R Kavanagh Side Effects of Drugs Annual 41, 219-225, 2019 | 1 | 2019 |
| Nortriptyline-induced oral ulceration: A case report W Olsufka, D Cabral, M McArdle, R Kavanagh Mental Health Clinician 8 (6), 309-312, 2018 | 1 | 2018 |
| Implementation of a Pharmacist-Led, Long-Acting, Injectable Cabotegravir/Rilpivirine Program for HIV-1 at Health System-Based Clinics in the New York Metropolitan Area NM Nguyen, R Kavanagh, M Gozar, D Cabral, H Goetz, A Cha, ... AIDS Patient Care and STDs 38 (3), 115-122, 2024 | | 2024 |
| American Association of Colleges of Pharmacy (AACP) Co-Curriculum Toolkit A Kanaan, A Mekonnen, A Staton, CC Lindsey, D Weldon, FG Khalafalla, ... | | 2022 |
| Medication Adherence Team Challenge for COVID-19 Vaccination Confidence and Adherence. FE Loh, J Zelnick, R Kavanagh | | 2021 |
| Tacrolimus dose adjustments when discontinuing protease inhibitor-based HIV regimen: A case report RK Kavanagh, A Spektor, E Kim JACCP Journal of the American College of Clinical Pharmacy 3 (8), 1671, 2020 | | 2020 |
| Trogarzo (ibalizumab-uiyk): A Novel Monoclonal Antibody Used for Salvage Therapy in Patients Living with Highly Drug-Resistant HIV Infection K Anderson, RK Kavanagh ACCP StuNews 38, 5, 2019 | | 2019 |
| Pharmacy: Evaluation of Goal-Directed Lipid-Lowering Therapy in People Living with HIV N Hernandez, M Sow, C Donatien, M Flores, R Kavanagh | | 2018 |
| P40 Initial outcomes of integrated community-based hepatitis C treatment for people who inject drugs: findings from the Queensland injectors’ health network L Morris, A Smirnov, A Kvassay, E Leslie, R Kavanagh, N Alexander, ... Journal of Virus Eradication 3, 25-26, 2017 | | 2017 |
| P28 Queensland injectors health network (QuIHN) treatment management program (TMP): hepatitis C virus (HCV) direct acting antivirals (DAA) full access for people who inject drugs R Kavanagh, T Nuckey, S Dodd, G Keogh, A Kvassay, N Alexander | | 2017 |
